Disease: Central neuroblastoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE We found seven miRNAs that significantly downregulated CHD5 expression in NB: miR-211, 17, -93, -20b, -106b, -204, and -3666. 26895110 2016
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 GeneticVariation disease BEFREE Recurrent alterations at relapse included mutations in the putative CHD5 neuroblastoma tumor suppressor, chromosome 9p losses, DOCK8 mutations, inactivating mutations in PTPN14 and a relapse-specific activity pattern for the PTPN14 target YAP. 26121086 2015
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma. 26245651 2015
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE Reintroduction of CHD5 into neuroblastoma cells represses WEE1 expression, demonstrating that CHD5 can function as a repressor in cells. 25247294 2014
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE These findings provide insights into the regulatory role of CHD5 during neurogenesis and suggest how inactivation of this candidate tumor suppressor might contribute to neuroblastoma. 23948251 2013
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 Biomarker disease BEFREE Unlike wild-type Chd5, Chd5-PHD mutants are unable to induce differentiation or efficiently suppress the growth of human neuroblastoma in vivo. 23318260 2013
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE In the present study, our results showed that genistein, an element found in soy, is an epigenetic modifier able to decrease hypermethylation levels of CHD5, and enhances the expression of CHD5 as well as p53, possibly contributing to inhibition of NB growth in vivo and tumor microvessel formation. 22960751 2012
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 Biomarker disease BEFREE Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. 20950435 2010
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 Biomarker disease BEFREE Among the best candidate genes predisposing to the development of neuroblastoma located in 1p36, the AJAP1 gene is the only gene present in the duplication while CHD5, TNFRSF25 and CAMTA1 are located outside of the rearrangement. 18672103 2009
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE CHD5 expression was very low or absent in neuroblastoma cell lines. 18577749 2008
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 Biomarker disease BEFREE Our mutation and expression analysis in neuroblastoma cell lines, combined with expression analysis in normal tissues, putative function and prior implication in neuroblastoma pathogenesis, suggests that the most promising TSG deleted from the 1p36 SRD is CHD5, but TNFRSF25, CAMTA1 and AJAP1 are also viable candidates. 17667943 2008
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.100 AlteredExpression disease BEFREE We examined a panel of neuroblastoma cell lines for CHD5 expression, which was consistently low or undetectable in all these lines. 12592387 2003